Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study

OBJECTIVE: To assess the efficacy of recombinant human erythropoietin (rhEPO) in amyotrophic lateral sclerosis (ALS). METHODS: Patients with probable laboratory-supported, probable or definite ALS were enrolled by 25 Italian centres and randomly assigned (1:1) to receive intravenous rhEPO 40 000 IU...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Neurol Neurosurg Psychiatry
Prif Awduron: Lauria, Giuseppe, Dalla Bella, Eleonora, Antonini, Giovanni, Borghero, Giuseppe, Capasso, Margherita, Caponnetto, Claudia, Chiò, Adriano, Corbo, Massimo, Eleopra, Roberto, Fazio, Raffaella, Filosto, Massimiliano, Giannini, Fabio, Granieri, Enrico, La Bella, Vincenzo, Logroscino, Giancarlo, Mandrioli, Jessica, Mazzini, Letizia, Monsurrò, Maria Rosaria, Mora, Gabriele, Pietrini, Vladimiro, Quatrale, Rocco, Rizzi, Romana, Salvi, Fabrizio, Siciliano, Gabriele, Sorarù, Gianni, Volanti, Paolo, Tramacere, Irene, Filippini, Graziella
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2015
Pynciau:
Neuromuscular
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4515982/
https://ncbi.nlm.nih.gov/pubmed/25595151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2014-308996
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg